Network successes and the five-year renewal application were presented at the 2018 Annual Meeting of the American Society for Experimental Neurotherapeutics poster session. The 
poster, presented March 9 at the meeting's poster presentation and reception, concluded that NeuroNEXT has met all of its initial goals within the first 7-year funding period; that Network sites hae demonstrated their capacity to effectively enroll subjects; and that the Network is primed for future collaborations with industry, academia and small business partners.
